Hepatitis A/B vaccine now with accelerated schedule

April 9, 2007

Combination vaccine providing coverage for both hepatitis A and B, can now be administered in an accelerated dosing schedule.

Twinrix, GlaxoSmithKline's combination vaccine providing coverage for both hepatitis A and B, can now be administered in an accelerated dosing schedule. The three-dose series of the vaccine can now be given within three weeks at 0, 7, and 21 to 30 days, followed by a booster at 12 months. Previously, immunization with the product required a 0-, 1-, and 6-month dosing schedule. Twinrix is indicated for prevention of the two diseases in adults age 18 years and older.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.